Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Blood cytokine biomarker signature detects tuberculosis and identifies dormant/active forms

Oct. 7, 2015

Bristol-Myers Squibb introduces NS5B inhibitors

Oct. 6, 2015

IAPs show promise for the treatment of M. tuberculosis and M. avium infections

Oct. 6, 2015

Biotron releases interim data from phase II study of BIT-225 in HCV

Oct. 5, 2015

PD/PK of topoisomerase inhibitor ACT-387042

Oct. 5, 2015

Pfizer acquires Nimenrix and Mencevax from GlaxoSmithKline

Oct. 5, 2015

Sato and Pola Pharma to comarket topical agent for tinea unguium

Oct. 5, 2015

XBiotech's 514G3 receives FDA fast track designation for serious infections

Oct. 2, 2015

Effect of TRL-1068 on biofilms

Oct. 2, 2015

Novavax receives Gates Foundation grant to develop RSV vaccine; reports phase I and II results

Oct. 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...